CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Option exercise Chief Accounting Officer acquired 5,967 shares (option exercise)
- 4 Open-market sale Exec. VP Chief Legal Officer sold 32,311 shares at an average $7.45 ($240,718)
- 4 Option exercise EVP,Global Marketing&Portfolio acquired 9,069 shares (option exercise)
- 4 Option exercise President and CEO acquired 293,586 shares (option exercise)
- 4 Option exercise EVP, International Markets acquired 83,042 shares (option exercise)
- 4 Option exercise EVP, Chief Financial Officer acquired 21,387 shares (option exercise)
- 4 Option exercise See "Remarks" acquired 5,710 shares (option exercise)
- 4 Open-market sale Executive VP, Global R&D sold 33,579 shares at an average $7.45 ($250,219)
- 4 Open-market sale Executive VP Global Operations sold 34,792 shares at an average $7.44 ($259,019)
- 4 Open-market sale EVP, North America Commercial sold 10,897 shares at an average $7.41 ($80,727)
- 4 Open-market sale Exec. VP, European Commercial sold 58,952 shares at an average $7.44 ($438,494)
- 4 Option exercise Chief Accounting Officer acquired 4,200 shares (option exercise)
- 4 Open-market sale Exec. VP Chief Legal Officer sold 6,452 shares at $8.14 ($52,533)
- 4 Open-market sale EVP,Global Marketing&Portfolio sold 5,311 shares at $8.14 ($43,243)
- 4 Option exercise President and CEO acquired 65,047 shares (option exercise)
Page 26 of 128 · 2,555 filings